103 results
424B3
CRVO
CervoMed Inc
6 Jun 24
Prospectus supplement
6:03am
the Chair of our board of directors, our Chief Executive Officer, or a majority of our directors are authorized to call a special meeting … of stockholders and only those matters set forth in the notice of the special meeting may be considered or acted upon at a special meeting of stockholders. Our
8-K
EX-3.3
CRVO
CervoMed Inc
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
by the stockholders of the Corporation at the special meeting of stockholders on August 15, 2023.
THIRD: That the Amendment was duly adopted in accordance
8-K
EX-99.1
ziok2sgnf7zxyof
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-3.5
6bulv1oz2p4h 3e
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
992 qvcfyo
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
425
EX-99.1
s2347 ekdi2a94
14 Aug 23
Business combination disclosure
4:16pm
8-K
EX-99.1
7hv6thpzjk47ip27h
14 Aug 23
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
4:15pm
425
n72xqd 0x1z
9 Aug 23
Business combination disclosure
4:02pm
425
EX-99.1
n72c4n10o55tyj83wif
9 Aug 23
Business combination disclosure
4:02pm
8-K
EX-99.1
wxo1wnti
9 Aug 23
Other Events
4:02pm
8-K
4k416
9 Aug 23
Other Events
4:02pm
425
2vvj6cz7rgk
3 Aug 23
Business combination disclosure
4:15pm
8-K
3fwb9ypn21f4u1vn4s
3 Aug 23
Other Events
4:15pm
425
EX-99.1
8jsnsdj27
3 Aug 23
Business combination disclosure
8:33am
8-K
EX-99.1
k60i wz3ihbtor4f
3 Aug 23
EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference
8:32am
424B3
i23knxf qbehggk8b
13 Jul 23
Prospectus supplement
4:32pm